Lost password ?
<< Back to Equity Research
Mouwasat Medical
MOUWASAT MEDICAL, IMMUNE AND GLEAMING
Apr 24 - Mouwasat Medical (Add, Saudi Arabia) has been more resilient than the Pan Arab composite companies and its peers over the last year. Surely, the sector index slump owes to the crash of NMC (Call ...
Executive summary
Conflict of Interest
Pages 37
Language English
Publish on April 24, 2020
€ 500
VAT Exl.
You might be also interested by these reports :
Apr 08 AM
Mouwasat Medical
Target pushed up by strong results
Mar 26 AM
Dallah Healthcare
Target boosted by a strong outlook
Mar 26 AM
Mouwasat Medical
Mouwasat Medical increases its net profit by 10%
Mar 15 AM
Dallah Healthcare
A slightly-weaker-than-expected Q4
FIND A REPORT
CONCEPT
Each company is researched in depth using a structured robust and transparent process.

AlphaMena provides analyses based upon exhaustive and homogeneous information which allows to compare stocks geographically, sector-wise, and by thematic.

The analyses include actuarial as well as off balance-sheet data.
BloombergStarmineFactsetReutersCapital IQ